Dr. Jacob Albert Misenheimer, MD

Dr. Misenheimer practices at OhioHealth Doctors Hospital in Columbus, Ohio, part of OhioHealth.

Dr. Misenheimer's NPI, 1154564557, was assigned on April 14, 2009. Dr. Misenheimer graduated from Wake Forest University School of Medicine in 2009. Dr. Misenheimer holds Ohio license 35.148039.

Dr. Misenheimer's primary practice is OhioHealth Doctors Hospital, at 5100 West Broad Street, Columbus, OH 43228 in Franklin County. The practice phone is (614) 544-2136.

Dr. Misenheimer's primary practice is OhioHealth Doctors Hospital in Columbus, Ohio, part of OhioHealth. Dr. Misenheimer is also affiliated with OhioHealth Riverside Methodist Hospital. The medical group on file is OhioHealth Physician Group. Dmand AI also links Dr. Misenheimer to 3 more hospitals, 4 medical groups, 2 group practices and clinics and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Misenheimer practices, 8 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Misenheimer's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Misenheimer is licensed in Ohio.

CMS data shows 1,005 Medicare services from Dr. Misenheimer across 12 procedure codes in 2024, for 559 Medicare patients. Medicare paid $63,019 for them.

CMS counts 559 Medicare patients who saw Dr. Misenheimer in 2024. The largest group is 65 to 74, with 221 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.73, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Misenheimer's median patient age at 73, with 43% women.

In 2024, Dr. Misenheimer wrote 1,474 Medicare Part D claims for 341 patients. 90% of them were for generic drugs. CMS names the drug for 1,343 of them, across 22 drugs with 11 or more claims each, at $119,885 in total drug cost. In 2023, CMS named 1,552 claims across 24 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Misenheimer for performance year 2024, reported through an alternative payment model (APM). Dr. Misenheimer accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 55 procedures of coronary angioplasty and stenting by Dr. Misenheimer, more than 86% of the clinicians it reports for that procedure.

Dmand AI links 7 papers to Dr. Misenheimer, published from 2015 to 2018. 2017 was the busiest year, with 2. The most frequent topics are Aortic Valve, Aortic Valve Stenosis and Postoperative Complications. Dr. Misenheimer's most frequent co-authors are Matthew Aaron Cavender, MD, Zahid Amin, MD and Gregory Thomas Means, MD.

CMS Open Payments shows 132 general payments to Dr. Misenheimer from 22 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 80% of the total. Boston Scientific Corporation paid the most, $2,166. It also lists 1 research payment totaling $220 in 2022.

Dr. Misenheimer graduated from Wake Forest University School of Medicine in 2009.